Avanos Medical, Inc. to Present at the 2024 CL King Annual Best Ideas Conference

Avanos Medical (NYSE: AVNS) has announced its participation in the CL King's 22nd Annual Best Ideas Conference 2024.

Rhea-AI Summary

Avanos Medical (NYSE: AVNS) has announced its participation in the CL King's 22nd Annual Best Ideas Conference 2024. Michael Greiner, the company's senior VP, CFO, and chief transformation officer, will engage in a fireside chat on September 16, 2024, at 9:30 a.m. Eastern Time. This virtual event provides an opportunity for investors to gain insights into Avanos Medical's strategies and performance.

The presentation will be accessible via webcast on the Investors section of the Avanos Medical website. For those unable to attend live, the webcast will be archived on the site for future viewing. This participation underscores Avanos Medical's commitment to investor relations and transparency in its operations.

Argus Session date unavailable

+0.80% session move Open Argus

Details

News Market Reaction – AVNS

The recorded move for AVNS in the trading session of this news was +0.80%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ALPHARETTA, Ga., Sept. 9, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer, and chief transformation officer will participate in a fireside chat at CL King's virtual 22^nd Annual Best Ideas Conference 2024 on Mon., Sept. 16 at approximately 9:30 a.m. Eastern Time.

A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.

About Avanos Medical, Inc.

Avanos Medical, Inc. (NYSE: AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, we are committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. We develop, manufacture and market our recognized brands globally and hold leading market positions in multiple categories across our portfolio. For more information, visit Avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn and Facebook.

View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-2024-cl-king-annual-best-ideas-conference-302242163.html

SOURCE Avanos Medical

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Avanos Medical (AVNS) presenting at the CL King Annual Best Ideas Conference 2024?

Avanos Medical (AVNS) is presenting at the CL King Annual Best Ideas Conference on Monday, September 16, 2024, at approximately 9:30 a.m. Eastern Time.

Who will represent Avanos Medical (AVNS) at the CL King conference?

Michael Greiner, senior vice president, chief financial officer, and chief transformation officer of Avanos Medical (AVNS), will represent the company at the CL King conference.

How can investors access Avanos Medical's (AVNS) presentation at the CL King conference?

Investors can access a webcast of Avanos Medical's (AVNS) presentation on the Investors section of the company's website. The webcast will also be archived for future viewing.

What type of presentation will Avanos Medical (AVNS) give at the CL King conference?

Avanos Medical (AVNS) will participate in a fireside chat format presentation at the CL King Annual Best Ideas Conference 2024.

Is the CL King Annual Best Ideas Conference 2024 an in-person or virtual event for Avanos Medical (AVNS)?

The CL King Annual Best Ideas Conference 2024 is a virtual event, as mentioned in the press release for Avanos Medical's (AVNS) participation.